Literature DB >> 2654295

Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids.

A M Lamas1, G V Marcotte, R P Schleimer.   

Abstract

Many recent studies have established the eosinophil as an active proinflammatory participant in a variety of disease states, most notably in allergic and helminthic disorders. In order to understand the effector role of eosinophils, factors which promote a selective eosinophilic infiltrate must be delineated. Eosinophil adherence to vascular endothelium is the first step in the formation of such an infiltrate. However, studies thus far have failed to identify factors which selectively activate the adherence of eosinophils. We have therefore speculated that the selective enrichment of eosinophils may result from nonselective recruitment of several leukocyte types combined with the production of local factors that promote the survival of eosinophils and not of other cells. We report that endothelial cell-conditioned medium selectively prolongs eosinophil survival up to 6 days in culture in a dose- and time-dependent manner. Stimulation of human vascular endothelial cells with IL-1 caused an increase in the generation of eosinophil survival-promoting activity, whereas stimulation with platelet-activating factor did not. Supernatants from human vascular endothelial cells cultured for 48 h in the presence of the glucocorticoid, dexamethasone, were less active in promoting eosinophil survival than control supernatants. These results suggest that factors produced locally in the vascular microenvironment may selectively promote eosinophil survival and may be under the regulation of cytokines and glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654295

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro.

Authors:  J P Caulfield; A Hein; M E Rothenberg; W F Owen; R J Soberman; R L Stevens; K F Austen
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

Review 2.  An overview of glucocorticoid anti-inflammatory actions.

Authors:  R P Schleimer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils.

Authors:  M P Hallsworth; T M Litchfield; T H Lee
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.

Authors:  E Her; J Frazer; K F Austen; W F Owen
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  Cyclosporin A increases the pulmonary eosinophilia induced by inhaled Aspergillus antigen in mice.

Authors:  J M Wang; M Denis; M Fournier; M Laviolette
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Antiinflammatory steroids inhibit granulocyte/macrophage colony-stimulating factor production by human lung tissue.

Authors:  M Kato; R P Schleimer
Journal:  Lung       Date:  1994       Impact factor: 2.584

7.  Blood eosinophil counts and arterial oxygen tension in acute asthma.

Authors:  D Spallarossa; O Sacco; D Girosi; G A Rossi
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.